Kamola Mirzaeva

5 ta ish

Neurology Department of Tashkent Medical Academy, Tashkent, Uzbekistan

1. Implication of CD4 for the progression of parkinsonism in patients with lupus erythematosus

   Sarvar Bebitov, Kamola Mirzaeva, G. Rakhimbaeva

   MaqolaAutoimmune Neurological Disorders and TreatmentsParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000648

2. Comparative analysis of efficiency of some antiepileptic drugs monotherapy with the assessment of the dynamics of quality of life in patients with epilepsy

   A. Ismatov, Kamola Mirzaeva

   MaqolaEconomic, Social, and Public Health Issues in Russia and GloballyJournal of the Neurological Sciences20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.008848

3. Confirmation of the neuroimaging significance of asymptomatic transient ischemic attack (TIA) in the course and prognosis of ischemic stroke

   A. Ismatov, G. Rakhimbaeva, Kamola Mirzaeva +1

   MaqolaNeurological Disorders and TreatmentsJournal of the Neurological Sciences20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.008885

4. Structure of motor and non-motor disorders in patients

   Kamola Mirzaeva

   MaqolaMuscle activation and electromyography studiesZenodo (CERN European Organization for Nuclear Research)20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.010374

5. Effectiveness of a Multidisciplinary Rehabilitation Program in Improving Motor Function and Quality of Life in Parkinson's Disease Patients

   Z. Akbarkhodjaeva, Kamola Mirzaeva

   MaqolaParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.001974